Our Certifications
Quality and compliance credentials supporting VitaMFG manufacturing.
Why Choose VitaMFG for Menopause Support Capsules?
- Black cohosh identity tied to *Actaea racemosa* root/rhizome and authenticated before use
- Extract standardization and marker method reviewed against the supplier COA
- Active soy isoflavones declared on an aglycone-equivalent basis
- Elemental magnesium calculated from the selected mineral source, not the compound weight
- Vitamin D3 delivered through a dry beadlet and controlled through a low-dose premix
- Soy allergen, liver-safety warning, medication and hormone-sensitive population review built into label development
Private Label Menopause Nutrition with Clear Ingredient Standards
VitaMFG develops menopause support capsules for adult women navigating perimenopause or menopause and looking for a daily dietary-supplement format without added hormone ingredients. The US-first concept combines 80 mg of authenticated black cohosh extract, 50 mg of active soy isoflavones, 100 mg of elemental magnesium and 25 mcg (1,000 IU) of vitamin D3 in two size 00 capsules taken with food.
This is a feasibility-gated formula rather than an approved commercial specification. Black cohosh standardization, soy-isoflavone equivalence, magnesium form, capsule fill, excipients, packaging and final claims must be closed through supplier documents, fit testing and finished-product data. The page can present a menopause-specific botanical layer and daily bone-nutrition layer, while avoiding claims about changing estrogen levels, replacing hormone therapy or treating disease. Final warnings must address soy, pregnancy, breastfeeding, liver conditions, hormone-sensitive conditions and medication use.
Menopause Support Capsule Product Directions
The platform can be adapted for different brand positions while retaining the same identity, dosage and safety controls.
Black Cohosh + Soy Isoflavone Capsules
The central menopause-category direction combines authenticated black cohosh with 50 mg of active soy isoflavones. Each botanical specification and calculation basis remains visible rather than being hidden inside a proprietary blend.
Menopause + Bone Nutrition Capsules
Add 100 mg of elemental magnesium and 25 mcg of vitamin D3 to create a daily mineral-and-vitamin layer relevant to adult bone nutrition, without presenting the formula as osteoporosis treatment or fracture prevention.
Perimenopause Daily Support Capsules
Position the two-capsule routine for adult women entering the menopausal transition. Claims are selected only after the final botanical specifications, target consumer and destination-market requirements are approved.
No-Added-Hormone Ingredient Capsules
The proposed formula contains no added hormone ingredient and is not hormone replacement therapy. Soy isoflavones still require careful consumer education and review for hormone-sensitive conditions.
Standardized Botanical Capsules
Build the commercial specification around authenticated plant identity, declared extract markers, test methods and traceable supplier documentation instead of relying on a generic “black cohosh” name.
Private Label Menopause Support Capsules
An OEM/ODM route covering raw-material qualification, formula fit, premixing, capsule filling, testing, packaging, warning review and commercial planning for the selected market.
Product Advantages for Menopause Support Capsules
The page focuses on four decisions buyers can verify from the approved formula and quality file.
80 mg Authenticated Black Cohosh
The plant part, species identity, extract ratio and standardization basis are reviewed before the botanical is approved.
50 mg Active Soy Isoflavones
The label target is expressed as active isoflavones using a stated aglycone-equivalent calculation rather than an undefined soy-extract weight.
Bone-Nutrition Layer Included
Elemental magnesium and vitamin D3 give the formula a daily nutrition story beyond a single menopause botanical.
Two-Capsule Daily Format
Two size 00 capsules create the intended daily serving, subject to bulk-density, flow, fill-weight and disintegration verification.
Standardize What the Label Names
An 80 mg black cohosh number is incomplete without the plant identity, plant part, extract specification and marker method. VitaMFG starts with authenticated *Actaea racemosa* root/rhizome and reviews the supplier's traceability, COA and adulteration controls. Soy isoflavones receive the same treatment: the 50 mg target must identify whether the result is reported as aglycone equivalents and how the individual isoflavone profile is calculated. This keeps the product story connected to measurable material facts rather than a generic botanical list.
Make Two Capsules Work in Practice
The four-actives concept must still fit, flow and remain uniform in two size 00 capsules. Development compares compact magnesium sources, verifies the real elemental-magnesium contribution and uses geometric dilution for the low-dose vitamin D3 beadlet. Black cohosh, soy extract and mineral bulk density determine whether direct filling is suitable or granulation is needed. Front, middle and end samples are checked for fill variation and applicable active uniformity. High-barrier packaging, light protection and desiccant requirements are then selected from stability and transport data.
Resource Center
Catalog Download
Explore VitaMFG capsule, gummy, powder, tablet and soft-chew development directions.
DownloadCertifications Download
Request the applicable production-site, ingredient-supplier and quality-system documents for qualification.
DownloadVideos
See the workflow from raw-material review and formula trial through filling, inspection and packaging.
Watch VideoFrom Formula Fit to Commercial Readiness
VitaMFG has more than five years of functional supplement development and manufacturing experience. For capsule projects, the team coordinates ingredient qualification, formula calculations, trial filling, analytical verification, packaging and commercial planning. The selected capsule production site's current certification scope and quality documents are supplied during customer qualification rather than assumed from another dosage form.
Each project moves through formula review, laboratory feasibility, initial testing, stability, pilot and commercial approval. Black cohosh identity, soy-isoflavone basis, elemental-magnesium calculation and vitamin D3 premix records remain connected to the finished specification. Capacity, MOQ and timing are confirmed only after the ingredients, capsule fit, testing, packaging and destination market pass feasibility review.
Menopause Support Projects for Different Markets
The same four-ingredient platform can support several commercial positions without making every page sound like a medical-treatment page.
Women's Life-Stage Brands
Build a focused perimenopause or menopause SKU around recognizable botanicals, a daily bone-nutrition layer and transparent warnings. The product page should explain who the formula is for, what each ingredient contributes and where medical guidance is necessary.
Practitioner-Informed Wellness Lines
Use authenticated botanicals, named standardization methods and a conservative claim file to support professional review. This direction is suitable for brands that want stronger ingredient documentation and clear medication and condition cautions.
Amazon and DTC Projects
Answer the questions consumers compare online: How many capsules are taken? Are they large? Does the product contain soy? Is black cohosh standardized? Is it hormone therapy? Clear answers about serving size, allergens and evidence boundaries reduce confusion before purchase.
Retail Private Label Projects
Start with the retailer's target consumer, shelf position, warning requirements, price architecture and packaging format. The formula, capsule count, stability program and substantiation route can then be reviewed against the intended launch market.
What Consumers Notice about Menopause Capsules
Public category reviews show that capsule size, aftertaste, stomach comfort, packaging and instructions to take the product with food affect continued use. These comments relate to third-party products; they are not reviews of a VitaMFG product and are not evidence that this formula produces a health outcome.
Menopause Support Capsules Product Specifications
| Parameter | Development Specification | Customization / Notes |
|---|---|---|
| Product Type | Menopause Support Capsules | Private Label / OEM / ODM |
| Development Status | Wave 3 / Feasibility gate | Conditional development; not a production formula |
| Target Consumer | Adult women in perimenopause or menopause | Final age, health and warning boundaries require label review |
| Black Cohosh Extract | Target: 80 mg per serving | Authenticated *Actaea racemosa* root/rhizome; marker and standardization to be approved |
| Soy Isoflavones | Target: 50 mg active isoflavones per serving | Aglycone-equivalent basis and individual profile must be stated |
| Elemental Magnesium | Target: 100 mg per serving | Citrate/oxide blend or compact chelate follows capsule-fit testing |
| Vitamin D3 | Target: 25 mcg / 1,000 IU per serving | Dry beadlet; premix and uniformity controls required |
| Serving Size | 2 capsules daily with food | Development baseline |
| Capsule Type | 2 × size 00 capsules | Shell composition and fill capacity remain to be approved |
| Formula Position | No added hormone ingredient | Not hormone replacement therapy; isoflavone cautions still apply |
| Process Direction | Sifting → geometric premix → optional granulation → filling → inspection → packaging | Final route follows flow, density and uniformity data |
| Packaging | High-barrier sealed pack | Desiccant and light-protection level follow stability data |
| Testing Direction | Identity, markers/assay, uniformity, microbiology, heavy metals, applicable contaminants, fill variation and disintegration | Final methods and limits follow approved materials and market |
| Allergen | Contains soy | Final label follows supplier and cross-contact review |
| Claim Boundary | Substantiated structure/function language only | No estrogen-balancing, HRT-equivalence or disease-treatment claim |
| OEM/ODM | Supported after feasibility gate | Review → Trial → Initial testing → Stability → Pilot → Commercial approval |
Start Your Supplement Manufacturing Project
Tell us what you want to manufacture — including dosage form, formulation requirements, packaging, target market, and expected volume. We'll review your project and recommend the next steps.
Share your project details — our team will review feasibility, process alignment, and next steps.
